Aurora Spine (TSE:ASG) has released an update.
Aurora Spine Corporation reported a significant increase in their first quarter financials for 2024 with a 35.7% rise in sales and a third consecutive quarter of positive EBITDAC. The company highlighted strong sales from their SiLO-TFX SI joint implant and SiLO allograft implant, which accounted for over a third of total sales. Growth is also attributed to an expanding sales force and advanced training programs for surgeons on their innovative spinal technology platforms.
For further insights into TSE:ASG stock, check out TipRanks’ Stock Analysis page.
